fda compounding semaglutide update says that the GLP-1 shortage is over Important Update: Changes to Compounded
Description
This side effect is generally temporary, dose-dependent, and reversible
Clinical data shows: For some, its more
Always speak with your healthcare provider if you have neurological symptoms or concerns
Since these formulations are not FDA-approved, there is a risk of contamination or improper dosing
